Navigation Links
PeaceHealth Laboratories' New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
Date:5/30/2012

SPRINGFIELD, Ore., May 30, 2012 /PRNewswire/ -- PeaceHealth Laboratories today announced the national availability and receipt of a federal patent for PtProtect™ (Patient Protect), a pain medication monitoring program offering the industry's highest levels of accuracy to detect prescription pain medication and identify potential negative drug interactions before they occur. PtProtect directly addresses the safety and financial concerns of prescription pain medication abuse by using the most sensitive and definitive assays to detect medication and illicit drugs.

In the most recent review period January – April, 2012, PeaceHealth Laboratories found that 35 percent of PtProtect test results returned discrepant results outside a patient's known prescriptions. Because PtProtect identifies patients who are taking or potentially diverting prescribed pain medications, taking pain medications that are not prescribed to them, or using drugs of abuse it has the potential to significantly reduce accidental deaths. (1)

"PtProtect saves lives, saves practices and saves communities money," said Ran Whitehead, Chief Executive Officer of PeaceHealth Laboratories. "Now physicians may know, with confidence, what pain medications their patient is taking and prescribe accordingly to the highest levels of safety. This patent validates our rigorous science and practical application of this life-saving technology. It also enables providers to protect their practices from uncertain liabilities including malpractice and patient mortality."

In recognition of PtProtect's technology and capabilities, the U.S. Patent and Trademark Office issued U.S. Patent No. 8,067,243 granting exclusive rights to PtProtect™.  

About PtProtect

PtProtect is a patented testing program that detects up to 38 prescribed medications and illicit drugs. Medications are revealed at the industry's lowest thresholds for the most sensitive, comprehensive detection of opiates and opioids, thus reducing the possibility of adverse drug interactions. Simple and timely reporting allows doctors to quickly determine if test results are consistent or inconsistent with patient prescriptions.

PtProtect is available through PeaceHealth Laboratories and may be administered by physicians nationwide. For information about PtProtect, visit www.ptprotect.com or call 800-826-3616.

About PeaceHealth Laboratories

PeaceHealth Laboratories is a division of PeaceHealth, a not-for-profit health care system with a mission of promoting personal and community health since 1890. PeaceHealth Laboratories provides comprehensive laboratory services throughout the Pacific Northwest (Oregon, Washington and Alaska), and specialty testing for clinicians and employers across the U.S. With 9 laboratories and 27 patient service centers in three states, PeaceHealth Laboratories is one of the largest laboratory systems in the Pacific Northwest. Learn more at www.peacehealthlabs.org

(1) Source: CNNMoney February 24, 2012


'/>"/>
SOURCE PeaceHealth Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PeaceHealth Standardizes Hematology Operations With Sysmex
2. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
3. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
4. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
5. Romark Laboratories Raises $18 Million in Institutional Financing
6. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
7. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
8. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
9. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
10. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
11. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2020)... ... February 28, 2020 , ... Jason Colleran, Founder of The ... winning throwing support sleeve. The Perfect Arm product made its first appearance last January ... world, and won “Best of Show” for the most innovative baseball product. , This ...
(Date:2/28/2020)... ... February 27, 2020 , ... Special Learning, Inc. ... with the mission to bring quality ABA intervention to the world. The ... suite comprised of curriculum and teaching materials to enable unfettered global access to ...
(Date:2/26/2020)... ... 2020 , ... Anchora Medical ("Anchora"), a portfolio company of ... round led by HOYA Corporation (“HOYA”) (ADR: HOCPY, TYO: 7741), a key strategic ... of single-use laparoscopic suturing devices. , HOYA, a global medical device and high ...
Breaking Medicine Technology:
(Date:2/20/2020)... ... February 20, 2020 , ... R3 Stem Cell, the nation's leader in ... 70 complimentary stem cell procedures on military veterans in 2019. The veterans ... , At the R3 Stem Cell Training Course for doctors , providers of all ...
(Date:2/20/2020)... ... February 20, 2020 , ... ... new release with next generation API integration functionality which enables agents to take ... Inc. in 2017, TMQuotes was the first white label software-as-a-service (SaaS) to give ...
(Date:2/19/2020)... (PRWEB) , ... February 19, 2020 , ... ... at Advanced Periodontics and Dental Implant Center of Connecticut, celebrate 30 years of ... patients with the same low fees that they charged in 1989, only thirty ...
(Date:2/19/2020)... MIAMI (PRWEB) , ... February 19, 2020 , ... ... to the film industry. While he is most known for his acting abilities ... exceptional host on the educational show “Behind The Scenes” with Laurence Fishburne. “Behind ...
(Date:2/19/2020)... ... February 19, 2020 , ... In 2017, the EU’s ... and requirements that currently govern medical device manufacturers under the Medical Devices Directive ... May 2020. Major changes from the previous MDD include:, , ...
Breaking Medicine News(10 mins):